Given Imaging Ltd.
2 Hacarmel Street
New Industrial Park PO Box 258
Yokneam,
20692
Israel - Map
Phone: 972 4 909 7777
Fax: 972 4 959 2466
Web Site: http://www.givenimaging.com
| Given Imaging Ltd. develops, manufactures, and markets diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. The company offers Given System, a wireless imaging system that uses disposable video capsules, PillCam capsules. The PillCam capsules when ingested by patients move through the gastrointestinal tract, and wirelessly transmit video, images, and data to a workstation. The company also offers PillCam Small Bowel capsule for detecting small bowel disorders; PillCam ESO capsule for visualizing the esophagus; and AGILE Patency Capsule and system, which is a dissolvable capsule that enables physicians to determine whether there are obstructions or strictures in the gastrointestinal tract that prevents passage of its PillCam Small Bowel capsule. In addition, Given Imaging Ltd. offers Bravo pH monitoring system, a wireless catheter-free pH test for gastro esophageal reflux disease. This system uses a disposable capsule that is temporarily placed in the esophagus to measure and transmit pH levels data to an external receiver. The company markets and sells its products through local distributors or representatives, as well as directly in Australia, Canada, France, Germany, the United States, and Israel. The company was founded in 1998 and is headquartered in Yoqneam, Israel. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Nachum Shamir , 54
Chief Exec. Officer, Pres |
N/A
| N/A | Mr. Yuval Yanai , 56
Chief Financial Officer |
N/A
| N/A | Mr. Kevin Rubey , 51
Chief Operations Officer |
N/A
| N/A | Dr. Manfred Gehrtz , 58
Pres of EMEA |
N/A
| N/A | Dr. Kazem Samandari , 58
Pres of Asia-Pacific/Japan |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
0.37 (2.35%) 
Profile
